Buy vs Start a Behavioral Health Practice

The real cost of starting a behavioral health practice

Most estimates for de novo behavioral health practice costs are optimistic. They account for licensing fees and furniture, but miss the three largest cost items: the credentialing gap, recruiting costs, and the time value of the founder's labor during the startup period.

**Build-out and setup costs:** - Office space build-out (therapy rooms, waiting area, admin space): $50,000–$150,000 - Furniture and equipment: $15,000–$30,000 - EHR/practice management software: $3,000–$8,000 per year - State licensing and application fees: $2,000–$15,000 depending on state and license type - Malpractice insurance: $5,000–$15,000 per year for a small group

Total setup: $75,000–$220,000 before you open.

**The credentialing gap:** New practices cannot bill commercial payers until each clinician and the practice entity complete credentialing — 60–180 days for most payers. During this period, you can see patients but you cannot collect from insurance. You can bill patients directly (self-pay), but at rates that cover maybe 30–50% of your operational costs.

**Recruiting costs:** Building a roster of 6–10 credentialed therapists from scratch means competing in a tight labor market. Expect to offer sign-on bonuses of $5,000–$15,000 per therapist plus competitive salaries. Recruiting 8 therapists costs $40,000–$120,000 in bonuses alone, before accounting for the time your first therapists spend seeing reduced caseloads while building up their patient panels.

**Working capital for losses:** A realistic 10-therapist practice operating at 60% capacity during months 1–12 might generate $60,000 per month in revenue but carry $95,000 per month in fixed costs. That's $35,000 per month in losses, or $420,000 in working capital burned through a 12-month ramp.

Total realistic de novo cost for a 10-therapist practice in a competitive market: **$535,000–$760,000** before reaching break-even cash flow.

• Build-out and setup: $75,000–$220,000
• Recruiting and sign-on bonuses: $40,000–$120,000
• Working capital during ramp: $300,000–$420,000 (12 months)
• Total to break-even: $535,000–$760,000

Acquisition cost vs de novo: a direct comparison

Take the same 10-therapist outpatient practice, but existing — $350K EBITDA, 60% commercial payer mix, 8 W2 therapists in place with established caseloads.

Acquisition cost at 6x EBITDA: **$2.1M**.

SBA 7(a) financing at 10% down: **$210,000 cash out of pocket** plus deal costs of $40,000–$60,000. Total cash required: $250,000–$270,000.

Compare that to $535,000–$760,000 de novo — with zero revenue for the first 12–18 months.

Post-acquisition, Day 1 cash flow: - EBITDA: $350,000 annually ($29,167 per month) - SBA debt service: $24,200 per month (10-year term, 7.5%) - Free cash flow before owner compensation: $4,967 per month

That is not a lot of cushion, but it is positive — and it grows as you add therapists and improve operational efficiency over Year 1 and Year 2.

De novo Day 1 cash flow: negative $35,000 per month.

The acquisition requires more capital upfront ($250K vs the first $100K of de novo setup costs), but the total capital required to reach positive operating cash flow is 2x–3x lower for the acquisition. And the acquisition carries no execution risk — the practice is already operating, the therapists are already credentialed, and the payer contracts are in place.

For SBA financing mechanics on a behavioral health acquisition, see SBA financing for behavioral health acquisitions and the SBA 7(a) loan guide.

• Acquisition cash required: $250K–$270K (SBA at 10% down)
• De novo total to break-even: $535K–$760K
• Acquisition Day 1 cash flow: positive
• De novo Day 1 cash flow: negative $35K/month

What acquisition buys that de novo cannot

The financial comparison understates the value of acquisition because it does not capture the hardest things to build from scratch.

**Payer contracts.** An existing practice has negotiated in-network agreements with commercial payers. These contracts specify reimbursement rates, authorization requirements, and billing procedures. Getting a new practice credentialed and contracted at competitive rates takes 12–24 months with each major payer. New practices almost always start at lower reimbursement rates than established providers — payers negotiate harder with new entrants who have no leverage.

**Patient relationships.** Therapy is relationship-intensive. Patients who have been seeing the same therapist for 2 years are not indifferent to change. An acquired practice brings those relationships with it (assuming proper therapist retention — see mental health practice acquisition contracts for how to protect them). De novo practices start with zero patient relationships.

**Referral networks.** Primary care physicians, psychiatrists, hospital social workers, and employee assistance programs (EAPs) refer patients to practices they know. Building referral relationships from scratch takes 18–36 months of consistent outreach. An established practice has referral sources that are already sending patients.

**Staff credentialing and licensure documentation.** Each therapist's credentialing file — licensure verifications, DEA registrations, payer credentialing applications, malpractice history — takes months to compile for a new hire. An established practice has a credentialing file for every therapist already in place.

These are not trivial advantages. They represent 2–4 years of relationship-building and administrative infrastructure that an acquisition transfers to you on day one.

• Payer contracts: negotiated rates and established relationships
• Patient relationships: active caseloads, no attrition risk from new start
• Referral networks: existing sources sending patients today
• Credentialing files: complete documentation for all therapists

When de novo makes sense

Acquisition wins in most scenarios, but there are three specific situations where starting from scratch is the correct strategic choice.

**Greenfield markets.** In underserved rural markets or rapidly growing suburban areas, there may be no established practices available for acquisition at reasonable prices — or at all. If you have a specific geographic opportunity with demonstrable unmet demand (long wait times, hospital referrals going unfilled, primary care physicians actively seeking referral partners), de novo may be your only path.

**License type unavailable.** Some behavioral health license types are genuinely scarce. If you want to operate a detox facility in a state that has a 2-year moratorium on new detox licenses, there may be no licensed detox to acquire at any reasonable price. The same applies to certain psychiatric residential treatment facility (PRTF) licenses and some CON-restricted bed types. In these cases, the license itself is the asset — and it only comes through the regulatory process.

**Highly specific clinical niche.** If you want to build an LGBTQ-affirming trauma practice, a Spanish-language outpatient clinic, or an adolescent day treatment program, and no practice of that type exists in your target market, a de novo build may be the only way to create the exact clinical model you want. Acquisitions require adapting to an existing model; de novo lets you build to specification.

**Partnership recruitment platform.** Some operators use a de novo practice as a recruiting vehicle — offering equity or partnership tracks to clinicians who want to build something together rather than being acquired. This is a longer-term play, but it can create a loyal clinical team with genuine ownership mentality that is hard to achieve through acquisition.

• Greenfield: no existing practices available, demonstrable unmet demand
• License scarcity: CON-restricted bed types or moratoriums on new licenses
• Clinical niche: build to a specific model that doesn't exist in market
• Partnership recruiting: equity-based team building as the growth strategy

Break-even analysis: de novo vs acquisition

Here is a direct break-even comparison using a 10-therapist outpatient practice in a mid-size metro.

**De novo scenario:** - Total capital invested to break-even: $600,000 - Time to positive monthly cash flow: 15 months - EBITDA at stabilization (month 18): $280,000 - Return on invested capital at stabilization: 47% annually ($280K / $600K) - Risk: high (no existing patient base, payer relationships, or staff)

**Acquisition scenario:** - Total capital invested (equity injection + deal costs): $270,000 - Time to positive monthly cash flow: Day 1 - EBITDA at close: $350,000 - Return on invested capital at close: 130% annually ($350K / $270K) before debt service - Risk: moderate (operational, not existential)

The acquisition returns more capital on less invested cash and starts generating positive cash flow immediately. The de novo catches up only if you are willing to accept 15+ months of losses and the execution risk of building from scratch.

One nuance: the acquisition requires $2.1M in debt financing that the de novo does not. If your constraint is access to capital rather than cash, de novo may be more accessible in the early stages — though the SBA 7(a) program has made acquisition financing accessible for operators with $250K to invest.

For operators who have evaluated this trade-off and decided acquisition is the right path, the buying a behavioral health practice guide covers every step of the acquisition process. For modality-specific valuation benchmarks, see behavioral health EBITDA multiples 2026.